Thomas Charles Reilly - Net Worth and Insider Trading

Thomas Charles Reilly Net Worth

The estimated net worth of Thomas Charles Reilly is at least $16,758 dollars as of 2025-05-18. Thomas Charles Reilly is the CFO of Cara Therapeutics Inc and owns about 1,050 shares of Cara Therapeutics Inc (CARA) stock worth over $16,758. Details can be seen in Thomas Charles Reilly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Charles Reilly has not made any transactions after 2022-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Thomas Charles Reilly

To

Thomas Charles Reilly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Charles Reilly owns 2 companies in total, including Cara Therapeutics Inc (CARA) , and Amarin Corp PLC (AMRN) .

Click here to see the complete history of Thomas Charles Reilly’s form 4 insider trades.

Insider Ownership Summary of Thomas Charles Reilly

Ticker Company Transaction Date Type of Owner
CARA Cara Therapeutics Inc 2022-03-03 Chief Financial Officer
AMRN Amarin Corp PLC 2023-02-21 SVP and CFO

Thomas Charles Reilly Latest Holdings Summary

Thomas Charles Reilly currently owns a total of 1 stock. Thomas Charles Reilly owns 1,050 shares of Cara Therapeutics Inc (CARA) as of March 3, 2022, with a value of $16,758.

Latest Holdings of Thomas Charles Reilly

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CARA Cara Therapeutics Inc 2022-03-03 1,050 15.96 16,758

Holding Weightings of Thomas Charles Reilly


Thomas Charles Reilly Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Charles Reilly has made a total of 2 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 57 shares on March 3, 2022, which brought Thomas Charles Reilly around $23,261.

Insider Trading History of Thomas Charles Reilly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Charles Reilly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Charles Reilly Ownership Network

Ownership Network List of Thomas Charles Reilly

No Data

Ownership Network Relation of Thomas Charles Reilly

Insider Network Chart


Thomas Charles Reilly Owned Company Details

What does Cara Therapeutics Inc do?

Who are the key executives at Cara Therapeutics Inc?

Thomas Charles Reilly is the Chief Financial Officer of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .

Cara Therapeutics Inc (CARA) Insider Trades Summary

Over the past 18 months, Thomas Charles Reilly made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 52,681 shares made by Christopher Posner , a net sale of 2,753 shares made by Scott Terrillion , and a net sale of 2,753 shares made by Joana Goncalves .

In summary, during the past 3 months, insiders sold 0 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,730 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,730 shares.

Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cara Therapeutics Inc Insider Transactions

No Available Data

Thomas Charles Reilly Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Charles Reilly. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Thomas Charles Reilly's mailing address is: Stamford Ct 06902.